Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Aug 2023 for Surgalign Holdings, INC., €42.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Christopher Thunander: trading record in brief
All filings by Christopher Thunander on record concern Surgalign Holdings, Inc., in the capacity of senior executive. We count 5 filings; the first trade dates from 1 October 2021 and the latest from 15 August 2023.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 16 August 2023 with a share grant (€42) in Surgalign Holdings, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Christopher Thunander
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
2,295 shares@ US$0.020.1% of flowCommon StockSEC:0001209191-23-046085:0
26 shares@ US$0.020.0% of flowCommon StockSEC:0001209191-23-045110:0
15,666 shares0Common StockSEC:0001209191-22-046185:0
130,000 shares@ US$0.459899.9% of flowCommon StockSEC:0001209191-22-010125:0
125,000 shares0Common StockSEC:0001209191-21-058580:0
5 of 5 declarations
